Publikacje

2013

1. Nieborowska-Skorska M, Hoser G, Hochhaus A, Stokłosa T, Skorski T. Anti-oxidant vitamin E prevents accumulation of imatinib-resistant BCR-ABL1 kinase mutations in CML-CP xenografts in NSG mice. Leukemia. 2013 Apr 22. doi: 10.1038/leu.2013.123. [Epub ahead of print]

2012

1. Klionsky D., Gołąb J., oraz wielu innych, Guidelines for the use and interpretation of assays for monitoring autophagy. Autophagy, 2012; 8(4): 445-544

2011

1. Virgili A, Koptyra M, Dasgupta Y, Głodkowska-Mrówka E, Stokłosa T. Nacheva EP, Skorski T. Imatinib sensitivity in BCR-ABL 1-positive chronic myeloid leukemia cells in regulated by the remaining normal ABL 1 allele. Cancer Res. 2011; 71(16): 5381-6

2010

1. Marek Jakóbisiak, Jakub Gołąb: Statins can modulate effectiveness of antitumor therapeutic modalities. Medicinal Research Reviews, 2010; 30 (1): 102-135.

2009

1. Urszula Mackiewicz, Michał Maczewski, Anna Konior, Jamaes O. Tellez, Dominika Nowis, Halina Dobrzyńska, Mark R. Boyett, Bohdan Lewartowski.: Sarcolemmal Ca2+ ATPase ability to transport Ca2+ gradually diminishes after myocardial infarction in the rat. Cardiovascular Research; 2009;  81: 546-554.

2008

1. Mrówka P., Głodkowska E., Nowis D., Legat M., Issat T., Makowski M., Szokalska A., Janowska S., Stokłosa T., Jakóbisiak M., Gołąb J.: Ciglitazone, an agonist of peroxisome proliferator-activated receptor gamma, exerts potentiated cytostatic/cytotoxic effects against tumor cells when combined with lovastatin. International Journal of Oncology; 2008; 32: 249-255

2007

1. Rink L, Slupianek A, Stoklosa T, Nieborowska-Skorska M, Urbanska K, Seferynska I, Reiss K, Skorski T. Enhanced phosphorylation of Nbs1, a member of DNA repair/checkpoint complex RAD50-Mre11-Nbs1, can be targeted to increase the efficacy of imatinib mesylate against BCR/ABL-positive leukemia cells. Blood. 2007 Apr 12; [Epub ahead of print]

2006

1. Kocanova S, Buytaert E, Matroule J-Y, Piette J, Golab J, de Witte P, Agostinis P. Heme oxygenase 1 induction by hypericin-mediated photodynamic therapy is regulated by the p38MAPK and PI3K pathways through the nuclear accumulation of NRF-2. Apoptosis (in press)

2005

1. Krszyna K, Stokłosa T. Czynnik indukowany przez hipoksję-1 (HIF-1): Budowa, regulacja ekspresji, funkcja oraz rola w progresji nowotworów. Post Biol Kom. 2005; 32(4): 707-728

2. Nowis D, Stokłosa T, Legat M, Issat T, Jakóbisiak M, Gołąb J. The influence of PDT on the immune response. Photodiagn. Photodyn. Ther. 2005; 2:283-298

2004

1. Stokłosa T., Słupianek A., Datta M., Nieborowska-Skorska M., Nowicki MO, Koptyra M. Skórski T. BCR/ABL recruits p53 tumor suppressor protein to induce drug resistance. Cell Cycle 2004, 3 (11), e93-e102